U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07527130) titled 'C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome' on April 07.
Brief Summary: The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Study Start Date: May, 2026
Study Type: OBSERVATIONAL
Condition:
COVID-19
Intervention:
DRUG: C11 ER176 Tracer
C11 ER176 tracer will be administered by IV, followed by PET imaging of the brain to evaluate for neuroinflammation
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Mayo Clinic
Information provided by (Responsible Party)...